Provider of an online digital insurance service intended to give everyone access to a healthy and productive life, empow
Provider of an online digital insurance service intended to give everyone access to a healthy and productive life, empowering the body and the mind.
Life and Health Insurance📍 Paris, FranceFounded 2016
Current Valuation
$5.9B
as of 2026-Q1
UNICORN
QL Price
$5.9B
0% vs last round
QuantLogix's current estimate for Alan, published 2026-11-12 — in line with the last disclosed round of $5.9B (2026-Q1).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round
$5.9B
2026-Q1
weight 0.65
Secondary market print
$5.9B
2026-06-27
weight 0.44
How this price has held up
No round has priced for Alan since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-11-12 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Alan, 2026-11-12 (61461afd2e589d79).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Alan going public?
No. Alan is private and has not filed to go public. There is no S-1 on file.
What is Alan's valuation in 2026?
Alan is valued at $5.9B as of 2026-Q1, set by its Later Stage VC ($117.63M, Mar 2026). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Alan filed an S-1?
No public S-1 is on file for Alan.
How much has Alan raised?
Alan has raised $866.31M in total, most recently a Later Stage VC of $117.63M in Mar 2026.
Is Alan publicly traded — can you buy Alan stock?
No. Alan is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Alan on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2016
HQ
Paris, France
Employees
850
Total Raised
$866.31M
Last Round
Later Stage VC — $117.63M (Mar 2026)
IPO Status
private
Fundraising Status
Later Stage VC · $117.63M · 8 mo ago
privateTotal raised $866.31M
Secondary Market
Implied price / share
$14.6
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Later Stage VC
$117.63M
Mar 2026
—
$5.9B
Talent Signal
Hiring trend
▲ Hiring uptrend
+12% vs 2026-10
Open roles
135
via ashby
Product-build share
24%
engineering, research, product, design
Trajectory
expanding
go-to-market push — Only 24% of open roles build product — hiring is concentrated in sales/marketing/ops (37 of 135 open roles are other).
No tracked executive churn; open roles trending up.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Freelance Doctor (GP) - Medical Chat & Teleconsultations - BelgiumFullstack Software Engineer (x/f/m) - Tech FoundationsFullstack Software Engineer (x/f/m) - Product PlatformMedical leadFounding engineer- Mo team (AI Health Companion)Platform Engineer (x/f/m) - Tech Foundations
Counted from Alan's live job board as of 2026-11-12; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Health CareHealth InsuranceInsurance
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2026-Q1. Refreshed quarterly.